Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA to Review Botox for Upper, Lower Limb Pediatric Spasticity
Autoimmune Disorders May Up Risk for Carpal Tunnel Syndrome
Asthma Associated With Osteoporosis, Other Bone Diseases
Gloperba Approved for the Prophylaxis of Gout Flares
Increased Risk of Pulmonary Embolism, Death in RA Patients Reported in Tofacitinib Postmarketing Study
NSAID Allergy May Increase Risk for Opioid Use Disorder
Uloric Labeling Updated With New Indication, Boxed Warning After Review of CV Safety Data
Risk of Tendon Rupture With Fluoroquinolone Use Examined
Chronic Low Back Pain Study Results Indicate Benefit With Tanezumab
Upadacitinib Gets FDA’s Priority Review for Treatment of Moderate to Severe RA
FDA to Review DMD Treatment Golodirsen
Rates of Osteonecrosis of the Jaw Low for Denosumab-Treated Women
Repeat Zilretta Administration Safe, Effective for Osteoarthritis Knee Pain, Says Study
MRI-Guided Tx Strategy Not Superior for Rheumatoid Arthritis
Pexidartinib Gets Priority Review for Tenosynovial Giant Cell Tumor
Long-Term Opioid Use With OA Varies Across States
Tofacitinib Benefits Sustained for Two Years in Patients With RA
Discontinuing TNFi Before Gestational Week 20 Is Feasible
